Evidence map›Paper›PMID 33342241›Full record

ArticleHypertension (Dallas, Tex. : 1979)2021

Association of Cumulative Systolic Blood Pressure With Long-Term Risk of Cardiovascular Disease and Healthy Longevity: Findings From the Lifetime Risk Pooling Project Cohorts.

Orna Reges, Hongyan Ning, John T Wilkins, Colin O Wu, Xin Tian, Michael J Domanski, Donald M Lloyd-Jones, Norrina B Allen

Open access · greenAbstract read
In one paragraph

Article in Hypertension (Dallas, Tex. : 1979), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
6.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 76 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Blood pressure targets in adults with hypertension.The Cochrane database of systematic reviews · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Observational
  9. Article
  10. Observational
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Orna RegesFrom the Department of Preventive Medicine, Northwestern University, Feinberg School of Medicine, Chicago, IL (O.R., H.N., J.T.W., D.M.L.-J., N.B.A.).
Hongyan NingFrom the Department of Preventive Medicine, Northwestern University, Feinberg School of Medicine, Chicago, IL (O.R., H.N., J.T.W., D.M.L.-J., N.B.A.).
John T WilkinsFrom the Department of Preventive Medicine, Northwestern University, Feinberg School of Medicine, Chicago, IL (O.R., H.N., J.T.W., D.M.L.-J., N.B.A.).
Colin O WuOffice of Biostatistics Research, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD (C.O.W., X.T.).
Xin TianOffice of Biostatistics Research, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD (C.O.W., X.T.).
Michael J DomanskiCardiovascular Institute, Icahn School of Medicine at Mount Sinai, NY (M.J.D.).
Donald M Lloyd-JonesFrom the Department of Preventive Medicine, Northwestern University, Feinberg School of Medicine, Chicago, IL (O.R., H.N., J.T.W., D.M.L.-J., N.B.A.).
Norrina B AllenFrom the Department of Preventive Medicine, Northwestern University, Feinberg School of Medicine, Chicago, IL (O.R., H.N., J.T.W., D.M.L.-J., N.B.A.).
Northwestern University · USNational Institutes of Health · USCardiovascular Institute of the South · US

Funding

Epidemiologic Study of Ethnicity and Lifetime Risks for Cardiovascular DiseaseR21HL085375 · NHLBI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI LLOYD-JONES, DONALD M · 2006 to 2007
$297k
NHLBI NIH HHS R21 HL085375
6 · The paper itself

Abstract

Hypertension is a major risk factor for cardiovascular disease (CVD), but previous studies have mostly been limited to a single exam, a single cohort, a short follow-up period, or a limited number of outcomes. This study aimed to assess the association of 10-year cumulative systolic blood pressure (BP) in middle age with long-term risk of any CVD, coronary heart disease, stroke, heart failure, all-cause mortality, and healthy longevity. Individuals (11 502) from 5 racially/ethnically diverse US community-based cohorts were included in this study once they met all the inclusion criteria: ≥10 year of observation in the included cohort, aged 45 to 60 years, free of CVD, and had ≥3 visits with BP exams over the preceding 10 years. For each participant, systolic BP level was predicted for each year of the 10-year prior inclusion, based on the available exams (median of 4.0; spread over, 9.1 [range, 7.2-10] years). Lower 10-year cumulative systolic BP was associated with 4.1 years longer survival and 5.4 years later onset of CVD, resulting in living longer life with a shorter period with morbidity. Models adjusted for sociodemographic characteristics, cardiovascular risk factors, and index systolic BP demonstrated associations of 10-year cumulative systolic BP (per 130 mm Hg×year change, the threshold for stage-1 hypertension) with CVD (hazard ratio [HR], 1.28 [95% CI, 1.20-1.36]), coronary heart disease (HR, 1.29 [95% CI, 1.19-1.40]), stroke (HR, 1.33 [95% CI, 1.20-1.47]), heart failure (HR, 1.12 [95% CI, 1.02-1.23]), and all-cause mortality (HR, 1.21 [95% CI, 1.14-1.29]). These findings emphasize the importance of 10-year cumulative systolic BP as a risk factor to CVD, above and beyond current systolic BP.

Indexed as

AgedBlood PressureCardiovascular DiseasesFemaleHealthy AgingHumansHypertensionIncidenceLongevityMaleMiddle AgedRiskRisk Assessmentblood pressurecardiovascular diseaseheart failurehypertensionlongevity

Identifiers

PMID33342241
PMCPMC7864675
OpenAlexW3116105976

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.